Delivery Order SPE2DB20D7066-SPE2DB25FC4FD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,969.84 to AmerisourceBergen Drug Corp for Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30-count). This firm fixed price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 12, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under...
- The Defense Logistics Agency awarded a delivery order valued at $5,083.49 to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 80-12.5 mg tablets in unit dose packaging (30 count) under a firm fixed price contract. This delivery order, which was competitively awarded with no set-aside designation, was executed on July 23, 2025, with an ultimate completion date of July 24, 2025. Performance will take place at the contractor's Corporate Office location in Conshohocken, Pennsylvania....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30-count). Valued at $1,463.52 with a firm fixed price structure, this non-set-aside competitive award was executed on July 29, 2025, with an ultimate completion date of July 30, 2025. The contract is issued as a child delivery order under...
- The Defense Logistics Agency awarded a delivery order valued at $5,086.20 to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30 count) on July 30, 2025, with completion targeted for July 31, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $3,007.04 to AmerisourceBergen Drug Corp for Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packages of 30 units. This competitive award, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's...
- The Defense Logistics Agency awarded a $14,672.56 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30-count). The contract is structured as a firm fixed price delivery order with a completion date of July 25, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this competitively awarded contract. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30-count) with a ceiling value of $5,768.16. This delivery order represents a firm fixed price contract with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for completion on August 6, 2025, and will be performed at AmerisourceBergen's corporate office location in...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $16,557.69 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Telmisartan-HCTZ 80-25 mg tablets in 30-count packages. The contract has a performance period through March 18, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp with a potential value of $999,999,999.00 and a performance...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,151.04 for Telmisartan-HCTZ 80-25 mg tablet unit dose packages (30 count) with an ultimate completion date of August 1, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. The contract covers the supply of this antihypertensive pharmaceutical product to support federal...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,510.53 firm fixed-price delivery order is for the supply of Telmisartan-HCTZ 80-12.5 mg tablets in 30-count packages. The contract has an ultimate completion date of July 10, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB25FC4FDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,833.03 to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30-count) on August 1, 2025, with an ultimate completion date of August 4, 2025. This is a firm fixed price, non-set-aside contract performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, valued at $999,999,999.00 and running through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor serving military and veteran healthcare systems through its comprehensive global pharmaceutical support vehicle. The company maintains extensive federal contracting relationships with the Defense Logistics Agency and its Medical Supply Chain, supplying a wide range of pharmaceutical products, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This particular delivery order for the antihypertensive combination drug reflects AmerisourceBergen's ongoing role as a prime vendor supporting the Defense Health Agency and other government healthcare systems with both routine and specialized pharmaceutical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 8/1/25 |